Target N. V. Biotech Purchases 50,000 Shares of Esperion Therapeutics Inc (ESPR) Stock


Esperion Therapeutics Inc major shareholder Target N. V. Biotech purchased 50,000 shares of Esperion Therapeutics stock in a transaction that occurred on Friday, June 29th. The shares were bought at an average cost of $39.48 per share, with a total value of $1,974,000.00.



from Biotech News